My main interests lie in the field of bioinformatics and systems biology. My main research work focuses on the exploration and research including complex diseases, non-coding RNA and network pharmacology by developing and using complex networks, machine learning, deep learning, graph theory, combinatorial mathematics and other methods, and has made a series of important progress. Research interests include pathogenic gene recognition, prediction of microRNA disease relationship, prediction of disease-related noncoding RNA environment factor combination, research of prediction of drug target, drug combination, prediction of protein interaction, etc. These research directions are the frontier and hot spot of cross research in mathematics, computer science, life science and many other fields in recent years, which have very important theoretical and practical significance. |
07/2019-til now |
Assistant Professor, College of Informatics, Huazhong Agricultural University, Wuhan, China |
12/2014-07/2019 |
Postdoctoral researcher, College of Informatics, Huazhong Agricultural University, Wuhan, China |
09/2009-12/2014 |
PhD in Computer Science and technology, Wuhan University, Wuhan, China |
09/2008-11/2009 |
Assistant Researcher,Nanyang polytechnic university, Singapore |
09/2006-06/2008 |
Master in Information Communication and Technology, Agder university in Norway |
12/2004-06/2005 |
Transfer in Computer Science,Hongkong Polytechnic Univeristy, HK |
09/2002-06/2006 |
Bachelor in Computer Science and technology, Wuhan University, Wuhan, China |
|
|
|
|
|
(1) Quan Y, Luo Z, Yang Q, Li J, Zhu Q, Liu Y, Lv B, Cui Z, Qin X, Xu Y, Zhu L*, Zhang H. Systems chemical genetics-based drug discovery: prioritizing agents targeting multiple/reliable disease-associated genes as drug candidates.29 May 2019. Frontiers in genetics. DOI: 10.3389/fgene.2019.00474 (2) Quan Y, Liu Y, Liu M, Wu Y, Zhu L, Luo Z, et al. (2018). Facilitating anti-cancer combinatorial drug discovery by targeting epistatic disease genes. Molecules, 23(4), 736. (3) Zhu L#, Zhu F. Identification association of drug-disease by using functional gene module for breast cancer[J]. Bmc Medical Genomics, 2015, 8(S2):1-8. (4) Zhu L#, Liu J. Integration of a prognostic gene module with a drug sensitivity module to identify drugs that could be repurposed for breast cancer therapy.[J]. Computers in Biology & Medicine, 2015, 61(C):163. (5) Zhu L#, Liu J, Liang F, et al. Predicting response to preoperative chemotherapy agents by identifying drug action on modeled microRNA regulation networks[J]. Plos One, 2014, 9(5):e98140. (6) Wang W, Liu J, Xiong Y, Zhu L, et al. Analysis and classification of DNA-binding sites in single-stranded and double-stranded DNA-binding proteins using protein information[J]. Iet Systems Biology, 2014, 8(4):176. (7) Zhu L#, Li J. Water Bioinformatics: An Association between Estrogen Degradation and 16S rRNA Motifs, International Conference on Bioinformatics and Biomedical Engineering. IEEE, 2010:1-4.. (8) Zhu L#, Liang F, Liu J, et al. Dynamic remodeling of context-specific miRNAs regulation networks facilitate in silico cancer drug screening, IEEE International Conference on Systems Biology. IEEE, 2011:292-302.. (9) Zhu L#, He C, Liu Y, et al. A systems chemical biology approach to identify targets of antibacterial agents: A case study of Chelerythrine and Rhein, IEEE International Conference on Bioinformatics and Biomedicine. IEEE, 2015:1047-1056. (10) Zhu L#, Yuan J. (2019). Predicting Potential Drug-Target Interactions with Multi-label Learning and Ensemble Learning. 10.1007/978-3-030-26969-2_69. |